This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

SAVINGS DEADLINE EXPIRES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 7-10, 2023 | In-Person + Digital
San Diego, CA, USAManchester Grand Hyatt San Diego
Register Now
Menu
Book Now

Vito LaVopa, PhD
Head Drug Substance at Rhythm Pharmaceuticals

Profile

Chemical Engineer: B.S. Tufts U., Ph.D. MIT Chemical engineer with 25+ years of experience with API development, scale-up and sourcing. Have worked on projects with small molecules, peptides, proteins, flow chemistry. Previous peptide experience supporting bivalirudin at The Medicines Co. Joined Rhythm Pharmaceuticals in 2020 after NDA approval of setmelanotide.

Agenda Sessions

  • Setmelanotide- Challenges in Commercializing and Scale-up

    , 11:45am
    View Session

Speakers at this event

Prev
Next
Neil Leatherbury
Vice President of CMC
Precision BioSciences

See Vito Speak

Register Now